Irish patients denied vital medicines by slow drug approval
• Patient’s cancer cleared by medicine in US • HSE had sought additional funding for drugs
Alice Merrigan, who was diagnosed with metastatic melanoma in 2014, did an interview with this newspaper last summer.
She had been diagnosed at just 34 years of age, and the cancer had spread to her brain, heart, lungs and liver.
She was, to put it crudely, riddled with the disease.
Merrigan travelled to the United States to gain access to a combination therapy that included a medicine called Opdivo (also called Nivolumab, or ...
